Rani Therapeutics Holdings, Inc. (RANI) Tops Q2 EPS by 1c
Tweet
Share
E-mail
Get Alerts RANI Hot Sheet
Join SI Premium – FREE
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q2 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $500 thousand.
For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
